Terri L. Klein to receive the WORLDSymposium™ 2021 Patient Advocate Leader (PAL) Award
Congratulations to Terri L. Klein, NPGC, the recipient of the WORLDSymposium™ 2021 Patient Advocate Leader (PAL) Award. Terri is the President and CEO at the National MPS Society, USA, is the co-Chair of the International MPS Network (IMPSN) and and the Council of Patient Advocates (COPA), representing the NIH-funded Lysosomal Disease Network (LDN) consortium of the NIH Rare Disease Clinical Research Network, and is a founding member of the Mucolipidosis Research Collaborative Network. Recently formed in 2019, this novel group of scientists, researchers, clinicians, and patient advocates are working in tandem to discover the scientific answers to provide therapies for ML II/III. She is a wife and mother of four, including Jennifer (28), her youngest that suffers from ML III.
WORLDSymposium™ 2021 REGISTRATION NOW OPEN
The live component of the 17th Annual WORLDSymposium will be held at the Manchester Grand Hyatt in San Diego, California, USA, from Monday, February 8 through Thursday, February 11, 2021. The health, safety and wellbeing of attendees, speakers, stakeholders and staff is of paramount importance. WORLDSymposium 2021 will be organized in accordance with the State of California health and safety standards.
The virtual component of WORLDSymposium 2021 will include a virtual exhibit hall, online poster sessions, on-demand content, all education sessions including Emerging Trends, general sessions and satellite symposia and virtual networking opportunities.
Call for Abstracts: WORLDSymposium™ Abstract Submission Now Closed: Deadline October 1, 2020
The deadline for submitting an abstract to WORLDSymposium was October 1, 2020 for review by the Program Committee. Abstracts must be submitted with the intention that they will be presented if selected. Authors should not submit abstracts if they do not plan to present at the meeting. Click here for more information.
Michael T. Osterholm, Phd, MPH to Deliver Keynote Address on Wednesday, February 10, 2021
The WORLDSymposium Planning Committee is excited to announce Michael T. Osterholm, Phd, MPH, will provide the Keynote Address on Wednesday, February 10, 2021 at the 17th Annual WORLDSymposium Scientific Meeting in San Diego, California, USA.
Dr. Osterholm is Regents Professor, McKnight Presidential Endowed Chair in Public Health, the director of the Center for Infectious Disease Research and Policy (CIDRAP), Distinguished Teaching Professor in the Division of Environmental Health Sciences, School of Public Health, a professor in the Technological Leadership Institute, College of Science and Engineering, and an adjunct professor in the Medical School, all at the University of Minnesota. From June 2018 through May 2019, he served as a Science Envoy for Health Security on behalf of the US Department of State. He is also on the Board of Regents at Luther College in Decorah, Iowa.
He is the author of the 2017 book, Deadliest Enemy: Our War Against Killer Germs, in which he not only details the most pressing infectious disease threats of our day but lays out a nine-point strategy on how to address them, with preventing a global flu pandemic at the top of the list.
Dr. Osterholm will be presenting the Keynote Address on Wednesday, February 10, 2021 at 8:00 AM PST. Make sure this session is on your calendar to hear Dr. Osterholm’s important messages.
WORLDSymposium 2021 will be Virtual and Live
Planning for WORLDSymposium 2021 is officially underway. The WORLDSymposium Planning Committee is taking into consideration formats that will be safe and feasible in February 2021. In anticipation of continued progress on a global level, the 17th annual live gathering will be in San Diego, CA at the Manchester Grand Hyatt Hotel, February 8-11, 2021. Additionally, there will be an alternative virtual format to supplement the live meeting for those who are unable to attend in person. Registration for both live and virtual attendance opens September 1, 2020.
- WORLDSymposium will be publishing updates by email every two-three weeks.
- The WORLDSymposium 2021 Program and Abstracts will again be published in the February 2021 “Lysosomes” issue of Molecular Genetics and Metabolism.
- There will be a new category for abstract submissions: “COVID-19 Pandemic: SARS-CoV-2 virology, pathobiology, immunization and treatment”, How is the pandemic influencing current practice, patient care, active research, and how are clinicians and researchers responding?
COVID-19 Aware
In light of the COVID-19 pandemic and its impact around the world, WORLDSymposium is mindfully monitoring the global situation, with a priority on the safety and well-being of all attendees, speakers, stakeholders and staff. WORLDSymposium is currently planning a live event, February 2021, in San Diego, California, at the Manchester Grand Hyatt Hotel. All attendees will be required to follow the State of California guidelines during the conference (face coverings, hand washing, social distancing, etc.)
Please continue to monitor this site (www.WORLDSymposia.org) for any updates or sign up to receive the latest information regarding the 2021 annual scientific meeting.
Please note, WORLDSymposium has added virtual registration as a viable and exciting option for those who are unable to participate in person.
WORLDSymposium Online 1-hour CME Session: Cardiovascular Implications in Fabry Disease Now Available
WORLDSymposium has released a free one-hour online CME session “Cardiovascular Implications in Fabry Disease: A Multidisciplinary Approach”, available to all health care practitioners. The course is available at CME University and at myCME.
There is a required pre-test and post-test in order to obtain the credit.
If you are already registered with CME University or myCME, you may use your user name and password to login and complete the activity. If you are a new user, you will be prompted to set up a login so you can save your progress and credit history.
Claiming Educational Credits for the 2020 WORLDSymposium Meeting
Information on how to claim education credits is given only to registered attendees and is available in the 2020 WORLDSymposium mobile app or by contacting us.
Preliminary Schedule at A Glance
All times are US Pacific Time Zone and schedule is subject to change
We’re Organizing Research on Lysosomal Diseases
Dates to Remember
August 1, 2020
Abstract submission website open.
September 1, 2020
Registration for the conference opens. Hotel registration opens for individuals who are able to attend the live conference in San Diego. Distribution of exhibitor prospectus and support opportunities to all prior supporting companies, and also available by request.
October 1, 2020
Deadline for submission of full-length manuscripts for peer-review in the “Lysosomes” issue of Molecular Genetics & Metabolism, February, 2021. Click here to access the Guide for Authors or to Submit Your Paper.
October 1, 2020
Deadline for abstract submission to WORLDSymposium 2021.
November 1 – December 1, 2020
Late breaking abstract submission open.
November 15, 2020
Notification of abstract acceptance for poster or platform presentation at WORLDSymposium 2021.
About WORLDSymposium
The goal of WORLDSymposium is to provide an interdisciplinary forum to explore and discuss specific areas of interest, research and clinical applicability related to lysosomal diseases. Each year, WORLDSymposium hosts a scientific meeting presenting the latest information from basic science, translational research, and clinical trials for lysosomal diseases. This symposium is designed to help researchers and clinicians to better manage and understand diagnostic options for patients with lysosomal diseases, identify areas requiring additional basic and clinical research, public policy and regulatory attention, and identify the latest findings in the natural history of lysosomal diseases.
Sign up for Updates
Click here to sign up for updates about the 17th Annual WORLDSymposium.
This symposium is designed for basic, translational and clinical researchers, patient advocacy groups, clinicians, and all others who are interested in learning more about the latest discoveries related to lysosomal diseases and the clinical investigation of these advances.